Paper7706497
Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin.
Wu X and 4 others. J Clin Invest, 1995. Cited by 358 papers, by iCite.
Cite this record
ConductScience Library. Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin. Papers, record 7706497. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7706497
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apoptosis | Major topic |
| Carcinoma | Major topic |
| Colorectal Neoplasms | Major topic |
| ErbB Receptors | Major topic |
| Receptor, IGF Type 1 | Major topic |
| Antibodies, Monoclonal | |
| Cell Cycle | |
| Cisplatin | |
| Drug Interactions | |
| Humans | |
| Insulin | |
| Insulin-Like Growth Factor I | |
| Phosphorylation | |
| Retinoblastoma Protein | |
| Tumor Cells, Cultured |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA-37641 | NCI NIH HHS | United States | U01CA037641 | PubMed and NIH | NIH RePORTER |
| CA-42060 | NCI NIH HHS | United States | R01CA042060 | PubMed and NIH | NIH RePORTER |
| R37CA042060 | NIH | NIH RePORTER | |||
| U19CA037641 | NIH | NIH RePORTER |
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6094961 | Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors. | Mol Biol Med | 1983 | https://conductscience.org/library/papers/6094961 | PubMed |
| 2 | 2961338 | An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture. | Biochem Biophys Res Commun | 1987 | https://conductscience.org/library/papers/2961338 | PubMed |
| 3 | 3502661 | Anti-epidermal growth factor receptor monoclonal antibodies may inhibit A431 tumor cell proliferation by blocking an autocrine pathway. | Trans Assoc Am Physicians | 1987 | https://conductscience.org/library/papers/3502661 | PubMed |
| 4 | 2845374 | Activation of a Ca2+-Mg2+-dependent endonuclease as an early event in castration-induced prostatic cell death. | Prostate | 1988 | https://conductscience.org/library/papers/2845374 | PubMed |
| 5 | 2910497 | SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. | Cell | 1989 | https://conductscience.org/library/papers/2910497 | PubMed |
| 6 | 3221874 | Blockade of the epidermal growth factor receptor inhibits transforming growth factor alpha-induced but not estrogen-induced growth of hormone-dependent human breast cancer. | Mol Endocrinol | 1988 | https://conductscience.org/library/papers/3221874 | PubMed |
| 7 | 2537147 | Characterization of epidermal growth factor receptor in primary human non-small cell lung cancer. | Cancer Res | 1989 | https://conductscience.org/library/papers/2537147 | PubMed |
| 8 | 2673542 | The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. | Cell | 1989 | https://conductscience.org/library/papers/2673542 | PubMed |
| 9 | 2795690 | Imaging of human tumor xenografts with an indium-111-labeled anti-epidermal growth factor receptor monoclonal antibody. | J Natl Cancer Inst | 1989 | https://conductscience.org/library/papers/2795690 | PubMed |
| 10 | 2608047 | Expression of transforming growth factor-beta in the rat ventral prostate during castration-induced programmed cell death. | Mol Endocrinol | 1989 | https://conductscience.org/library/papers/2608047 | PubMed |
| 11 | 2608059 | Anti-epidermal growth factor receptor antibodies inhibit the autocrine-stimulated growth of MDA-468 human breast cancer cells. | Mol Endocrinol | 1989 | https://conductscience.org/library/papers/2608059 | PubMed |
| 12 | 4561027 | Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. | Br J Cancer | 1972 | https://conductscience.org/library/papers/4561027 | PubMed |
| 13 | 632300 | The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. | J Biol Chem | 1978 | https://conductscience.org/library/papers/632300 | PubMed |
| 14 | 7014501 | Cell death: the significance of apoptosis. | Int Rev Cytol | 1980 | https://conductscience.org/library/papers/7014501 | PubMed |
| 15 | 6263874 | Demonstration of two subtypes of insulin-like growth factor receptors by affinity cross-linking. | J Biol Chem | 1981 | https://conductscience.org/library/papers/6263874 | PubMed |
| 16 | 6268987 | Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells. | Nature | 1981 | https://conductscience.org/library/papers/6268987 | PubMed |
| 17 | 7031900 | Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor. | Science | 1982 | https://conductscience.org/library/papers/7031900 | PubMed |
| 18 | 6298788 | Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6298788 | PubMed |
| 19 | 6188757 | A monoclonal antibody to the human epidermal growth factor receptor. | J Cell Biochem | 1982 | https://conductscience.org/library/papers/6188757 | PubMed |
| 20 | 6309774 | Somatomedin-C stimulates the phosphorylation of the beta-subunit of its own receptor. | J Biol Chem | 1983 | https://conductscience.org/library/papers/6309774 | PubMed |
Cited by86
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 358 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37998753 | Recruiting In Vitro Transcribed mRNA against Cancer Immunotherapy: A Contemporary Appraisal of the Current Landscape. | Curr Issues Mol Biol | 2023 | https://conductscience.org/library/papers/37998753 | PubMed |
| 37171501 | Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis. | Diabetologia | 2023 | https://conductscience.org/library/papers/37171501 | PubMed |
| 37160880 | Post-translational covalent assembly of CAR and synNotch receptors for programmable antigen targeting. | Nat Commun | 2023 | https://conductscience.org/library/papers/37160880 | PubMed |
| 37060010 | Effect of insulin resistance on CAC scores in cancer survivors. | Cardiooncology | 2023 | https://conductscience.org/library/papers/37060010 | PubMed |
| 36991401 | Association of novel and conventional obesity indices with colorectal cancer risk in older Chinese: a 14-year follow-up of the Guangzhou Biobank Cohort Study. | BMC Cancer | 2023 | https://conductscience.org/library/papers/36991401 | PubMed |
| 36557227 | Metabolomic Analysis of Renal Cell Carcinoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. | Metabolites | 2022 | https://conductscience.org/library/papers/36557227 | PubMed |
| 36343387 | Genotype-Tailored ERK/MAPK Pathway and HDAC Inhibition Rewires the Apoptotic Rheostat to Trigger Colorectal Cancer Cell Death. | Mol Cancer Ther | 2023 | https://conductscience.org/library/papers/36343387 | PubMed |
| 35296101 | Diabetes and Colorectal Cancer Risk: Clinical and Therapeutic Implications. | J Diabetes Res | 2022 | https://conductscience.org/library/papers/35296101 | PubMed |
| 34803263 | Molecular docking analysis of HER-2 inhibitor from the ZINC database as anticancer agents. | Bioinformation | 2020 | https://conductscience.org/library/papers/34803263 | PubMed |
| 34354591 | Phytochemicals as Potential Chemopreventive and Chemotherapeutic Agents for Emerging Human Papillomavirus-Driven Head and Neck Cancer: Current Evidence and Future Prospects. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34354591 | PubMed |
| 33864051 | Precision oncology in metastatic colorectal cancer - from biology to medicine. | Nat Rev Clin Oncol | 2021 | https://conductscience.org/library/papers/33864051 | PubMed |
| 33814909 | EGFR Targeted Cetuximab-Valine-Citrulline (vc)-Doxorubicin Immunoconjugates- Loaded Bovine Serum Albumin (BSA) Nanoparticles for Colorectal Tumor Therapy. | Int J Nanomedicine | 2021 | https://conductscience.org/library/papers/33814909 | PubMed |
| 32082070 | Amphiregulin Regulates Phagocytosis-Induced Cell Death in Monocytes via EGFR and the Bcl-2 Protein Family. | Mediators Inflamm | 2019 | https://conductscience.org/library/papers/32082070 | PubMed |
| 31165040 | Cetuximab-Containing Combinations in Locally Advanced and Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. | Front Oncol | 2019 | https://conductscience.org/library/papers/31165040 | PubMed |
| 31130830 | Targeted Therapy in Metastatic Colorectal Cancer: Current Standards and Novel Agents in Review. | Curr Colorectal Cancer Rep | 2019 | https://conductscience.org/library/papers/31130830 | PubMed |
| 29765556 | Antibody-assisted target identification reveals afatinib, an EGFR covalent inhibitor, down-regulating ribonucleotide reductase. | Oncotarget | 2018 | https://conductscience.org/library/papers/29765556 | PubMed |
| 29628974 | The effect of near-infrared fluorescence conjugation on the anti-cancer potential of cetuximab. | Lab Anim Res | 2018 | https://conductscience.org/library/papers/29628974 | PubMed |
| 28827625 | Metabolic unhealthiness is an important predictor for the development of advanced colorectal neoplasia. | Sci Rep | 2017 | https://conductscience.org/library/papers/28827625 | PubMed |
| 28197803 | Obesity-related parameters and colorectal adenoma development. | J Gastroenterol | 2017 | https://conductscience.org/library/papers/28197803 | PubMed |
| 27655662 | Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer. | Oncotarget | 2016 | https://conductscience.org/library/papers/27655662 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EGF | 1950 | PubTator's text mining | https://conductscience.org/library/genes/1950 | NCBI Gene |
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| IGF1 | 3479 | PubTator's text mining | https://conductscience.org/library/genes/3479 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7706497
GET https://conductscience.org/api/papers/v1/7706497/references?page=2